Roos Jutten
@roosjutten
PhD, neuropsychologist | @AlzheimerAms | Alzheimerโs disease, cognition, measurement, remote digital assessment
ID: 1055399679717007360
25-10-2018 10:04:26
394 Tweet
888 Takipรงi
701 Takip Edilen
It was great to see so many (old and new!) faces at our #AAIC24 CognitionPIA day. ๐ข To all PIA members: please attend our business meeting in September to learn more about our goals and activities for next year (keep an eye out for ISTAART emails announcing the date and time).
I'll be presenting at poster #552 today #AAIC24 comparing the utility of mean vs. intraindividual variability metrics of #smartphone mobility phenotypes to predict cognition in older adults. If you're interested in #digitalphenotyping or #IIV stop by! Temple Cognitive Neuropsychology Lab ISTAART
Really enjoyed this fantastic session with excellent presentations by fellow IMPACT-AD Alumni Scholars! ๐๐ป๐Andrew Kiselica, PhD, ABPP Louisa Thompson
I am excited to share our work, out now in The Lancet Neurology, showing cell-based measures of gamma-secretase activity and amyloid production predict clinical, cognitive and biomarker features in autosomal dominant AD. Link to paper: tinyurl.com/ye2a3d5u Alzheimer's Association #AAIC
Multi-day learning curves (MDLCs) scores diminish ax Biomarker groups, but not uniformly. A+ status regardless of T-status is associated with diminished Digit Signs MDLCs, whereas being T+ drives worse performance on Face Name and Groceries Prices MDLCs. Good work Roos Jutten ๐
#AAIC24: what a ride!!๐ข ๐ It was so great to learn, present and discuss #Alzheimer's research with so many dear colleagues and friends! ๐ ๐๐ป Thanks Alzheimer's Association for making this incredible week possible! Time to rest up now. See you in Toronto next year! ๐ #EndAlz
We are so happy to have you Maria Celeste Lรณpez Moreno!!
What constitutes a clinically meaningful change in everyday functioning for individuals with Alzheimerโs disease, and how can you measure this? ๐๐ต๏ธ Sign up for the webinar below! CognitionPIA Clinical Trials Advancement and Methods PIA IMPACT-AD
๐๐CognitionPIA members, we need your input! In preparation for our ISTAART Cognition PIA 2024 Year in Review webinar, please fill out this survey to submit publications & advancements from 2024 that you would like us to highlight. Deadline *Dec 9th*! ๐alz.surveymonkey.com/r/SLH6BMW
Excited to share our Framingham Heart Study paper in ANA Journals!๐ง Sex-specific links between stroke risk factors and subclinical vascular brain injury support tailored prevention strategies in aging.๐doi.org/10.1002/ana.27โฆ Big thanks to Sudha Seshadri, MD, Alexa, Matt, Rachel Buckley ๐จ๐ฆ๐บ๐จ & team!
๐ง ๐ซ Happening next week (Jan 14th): our CognitionPIA Year in Review webinar, during which we will discus exciting highlights in #cognition and dementia research from 2024, and look ahead to 2025. We look forward to your attendance! Register using the link below. #EndAlz
๐Our paper in npj Digital Medicine! Assessing learning over days through #remote #digital testing reveals subtle memory differences across individuals with different amyloid and tau biomarker profiles.๐ฑ๐๐ง Harvard Aging Brain Study BRANCH @MGH_RI Brigham and Women's Neurology doi.org/10.1038/s41746โฆ
Excited to share our official publication JMIR Publications JMIR Human Factors with proof-of-concept results that #smartphone #digitalphenotyping is feasible with older adults and yields clinically useful information on risk and resilience factors for aging and #ADRD humanfactors.jmir.org/2024/1/e59974